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Abstract
Background: DNA methylation is an epigenetic mechanism that has been increasingly investigated in observational human
studies, particularly on blood leukocyte DNA. Characterizing the degree and determinants of DNA methylation stability can
provide critical information for the design and conduction of human epigenetic studies.
Methods: We measured DNA methylation in 12 gene-promoter regions (APC, p16, p53, RASSF1A, CDH13, eNOS, ET-1, IFNc, IL-
6, TNFa, iNOS, and hTERT) and 2 of non-long terminal repeat elements, i.e., L1 and Alu in blood samples obtained from 63
healthy individuals at baseline (Day 1) and after three days (Day 4). DNA methylation was measured by bisulfite-PCR-
Pyrosequencing. We calculated intraclass correlation coefficients (ICCs) to measure the within-individual stability of DNA
methylation between Day 1 and 4, subtracted of pyrosequencing error and adjusted for multiple covariates.
Results: Methylation markers showed different temporal behaviors ranging from high (IL-6, ICC = 0.89) to low stability (APC,
ICC = 0.08) between Day 1 and 4. Multiple sequence and marker characteristics were associated with the degree of variation.
Density of CpG dinucleotides nearby the sequence analyzed (measured as CpG(o/e) or G+C content within 6200bp) was
positively associated with DNA methylation stability. The 39 proximity to repeat elements and range of DNA methylation on
Day 1 were also positively associated with methylation stability. An inverted U-shaped correlation was observed between
mean DNA methylation on Day 1 and stability.
Conclusions: The degree of short-term DNA methylation stability is marker-dependent and associated with sequence
characteristics and methylation levels.
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Introduction
DNA methylation is a well-studied epigenetic mechanism that
has been increasingly investigated in epidemiology studies in
relation to a variety of risk factors and health-related conditions,
including aging, prenatal, early- and adult-life risk factors,
changing environments, and disease outcomes. Albeit DNA
methylation shows dynamic changes during developmental stages,
DNA methylation markings have been suggested to be relatively
stable over time in adult individuals [1]. DNA methylation
changes can be replicated through cell mitosis and persist even in
the absence of the conditions that established them [1]. Due to its
stability, DNA methylation has been suggested to be particularly
well suited to represent ‘the interactions of genes with their
environment, which bring the phenotype onto being’ [1], and to
‘record a variety of dietary, lifestyle, behavioral, and social cues’
[2].
Experimental models and human studies, however, indicate that
DNA methylation can exhibit different temporal behaviors,
varying between the nearly absolute stability of the DNA sequence
and the rapid variations typical of mRNA levels. DNA methyl-
ation in imprinted genes, for instance, is established in early
embryogenesis and is believed to remain relatively stable
throughout the life-course [3]. Some non-imprinted genes, as well
as non-coding repeat elements, have been suggested to undergo
slow progressive changes in DNA methylation through aging [4].
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On the other hand, some other non-imprinted sequences – such as
the IL-2 promoter – have been demonstrated to undergo profound
changes in DNA methylation as rapidly as within 20 minutes after
an exogenous challenge [5]. However, no in-vivo human data are
yet available to help distinguish sequences that undergo rapid
changes in DNA methylation from those with more stable
methylation levels. This information would be relevant for
effective design of epidemiology studies, as well as for statistical
analysis of methylation data. In studies of risk factors that operate
over a short timeframe, such as investigations on triggers of
cardiovascular events including air pollution, alcohol, and cocaine
abuse [6,7], investigators may be interested in focusing on
epigenetic markers that vary their methylation levels over a
relatively short timeframe. Conversely, longitudinal studies eval-
uating effects of cumulative risk factor exposures and associations
with risk of chronic diseases would best avoid expending resources
and statistical power on sequences with rapid DNA variation.
The International Human Epigenome Consortium is expected
to map 1,000 reference epigenomes and define the level of
variation that exists between individuals and across different tissues
[8]. However, no information is available on the dynamics of DNA
methylation changes in normal tissues and to identify genomic
characteristics that may be associated with rapid variations in
methylation changes. In various studies, DNA methylation shows
genomic region specific changes in terms of CpG density. CpG-
rich regions (generally called CpG islands) are commonly
unmethylated in normal human tissues and have been found to
show DNA methylation changes in normal healthy individuals
through aging [9]. CpG-island shores – i.e., areas with low CpG
density bordering CpG-rich regions known as CpG islands - show
frequent variations of DNA methylation between cancer and
normal tissues, as well as in stem cells compared with differentiated
tissues [10]. On the other hand, a low CpG density area, distinct
from shores or CpG islands, was identified as a primary region for
the transgenerational differentially methylated regions (DMR)
[11]. In vitro data show that, transcription complexes, such as
transcription factors, nucleosome occupancy, chromatin contents
[12,13], show differential binding preference to genomic regions
depending on CpG density. DNA methyltransferases (DNMTs)
interactions with the transcription machinery [14] may bring
DNA methylation variation dependent on CpG density. Also,
proximity to repeat elements is another genomic feature that
might affect DNA methylation stability. For instance, Alu repeat
elements have been proposed as methylation centers that can
contribute to propagate DNA methylation to nearby gene
promoter CpGs [15,16,17].
Blood DNA from unfractionated peripheral leukocytes has been
most frequently used in DNA methylation analyses in epidemiol-
ogy studies [18], as it can be easily obtained from living human
individuals and used for DNA methylation analysis following
standard collection and isolation techniques. Due to the interest in
the investigation of genetic and molecular markers, a wealth of
epidemiology studies have collected and stored blood leukocyte
DNA, which can be readily used for DNA methylation analyses.
Peripheral blood leukocytes have been suggested to directly or
indirectly participate in the pathophysiology of a wide array of
human diseases that are initiated by or associated with systemic
inflammatory and immune responses, including – but not limited
to – immune, infectious, cardiovascular, and respiratory disease
[19]. As a result, DNA methylation analyses on blood DNA have
been conducted in investigations of ischemic heart disease [20,21],
stroke [21], autoimmune connective-tissue disease [22], as well as
of psychiatric disease [23], neurological disorders [24], and various
cancers [25].
In the present study, we report analyses on DNA methylation
markers with different genomic characteristics aimed at: i)
characterizing short-term variability in blood DNA methylation;
and ii) identifying characteristics associated with the variability in
DNA methylation levels. We investigated a population exposed to
an environmental risk factor, i.e., metal-rich airborne particulate
matter (PM), which has been previously associated with short-term
variations in DNA methylation [26]. We used statistical methods
accounting for measurement error from pyrosequencing analyses,
as well as potential effects on DNA methylation from modifications
in the proportion of leukocyte cell types. We show examples of
markers with rapid variation in DNA methylation, and we
demonstrate sequence and other marker characteristics that are
associated with DNA methylation stability.
Materials and Methods
Study Participants
The present study is based on 63 male healthy workers of a
Northern-Italy electric steel plant, free of cancer, cardiovascular,
and pulmonary disease [26,27]. Characteristics and exposure
levels of the study participants were reported previously [26]. An
in-person interview collected detailed individual and lifestyle
information. For each participant, we obtained blood samples
on two different days: on the first day of a workweek (Day 1); and
after three days of work (Day 4). This study was approved by
Universita` degli Studi di Milano and IRCCS Ca’ Granda
Maggiore Policlinico Hospital and all samples were collected
according to the institutional review board of the Universita` degli
Studi di Milano and IRCCS Ca’ Granda Maggiore Policlinico
Hospital in accordance with institutional guidelines. Individual
written informed consent was obtained from all participants before
the study.
Blood Sample Collection and DNA Methylation Analyses
Day 1 and 4 blood samples were collected and processed using
the same protocols, as previously described [26]. After purification,
Day 1 and Day 4 DNA samples were interspersed across plates to
minimize plate effect bias. We measured DNA methylation in 12
genes [Adenomatous polyposis coli (APC), cyclin-dependent kinase
2a (p16), tumor-protein p53 (p53), Ras-association (RalGDS/AF-6)
domain family member 1 (RASSF1A), cadherin 13 (CDH13), nitric
oxide synthase 3 (eNOS), endothelin-1 (ET-1), interferon, gamma
(IFNc), interleukin-6 (IL-6), tumor-necrosis factor a (TNFa), nitric-
oxide synthase 2, inducible (iNOS), and telomerase reverse
transcriptase (hTERT)]; and two repeat elements (L1 [also known
as LINE-1] and Alu). All methylation markers were selected as
candidates for their potential participation in pathway activated by
PM exposures. Bisulfite-PCR-pyrosequencing was performed as
previously described [26]. PCR primers and PCR conditions for
promoter regions of genes and repeat elements are listed in Table
S1. All post-PCR products were run twice on pyrosequencing to
increase precision.
Characteristics of the DNA Methylation Markers
In order to study the correlation between sequence character-
istics and stability of each methylation marker, we determined the
following characteristics: GC content (G+C) and ratio of observed-
to-expected CpG [CpG(o/e)] at 6200bp from the first CpG site
evaluated; and distance of any repeat elements from target CpGs
in 59 or 39 direction (Table 1). GC content and CpG(o/e) data
were obtained using the web-based program cpgplot (http://www.
ebi.ac.uk/Tools/emboss/cpgplot/#andNewcpgseek). The dis-
tance of repeat elements from target CpGs was calculated
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manually using the UCSC web browser (http://genome.ucsc.edu/
). We used information on ten classes of repeats, included short
and long interspersed nuclear elements (SINEs and LINEs), long
terminal repeat elements (LTRs), DNA repeat elements, simple
repeats (micro-satellites), low-complexity repeats, satellite repeats,
RNA repeats (including RNA, tRNA, rRNA, snRNA, scRNA,
srpRNA), and other repeats (including repeats classified as class
RC [Rolling Circle] and ‘unknown’).
Statistical Analysis
To account for the data structure, we used the following
random-effect model:
Yijk~azuizvijzeijk ð1Þ
where Yijk represents the methylation value for individual
i=1,2,…,63, on Day j = 1,2, for technical pyrosequencing
replicate k = 1,2; a is an overall intercept, and ui and vij are
random effects associated with individual and day within
individual; eijk is the error term. As is standard in linear mixed
effects models, we assume the random effects and residual errors
are normally distributed: ui,N (0, sID); vij,N (0, sID, Day); and
eijk,N (0, sRun), yielding three variance components (sID, sID,
Day, sRun) in the model. The residual variance sRun captures the
pyrosequencing measurement error measured by the technical
replicates (pyrosequencing runs) on the same individual and day.
We used intraclass correlation coefficients (ICCs) to estimate DNA
methylation stability. We expected the ICCs to vary between 0
(i.e., no correlation between Day 1 and 4) and 1 (i.e., maximum
stability between Day 1 and 4). Define sTOT=sID+sID, Day+
sRun. We calculated two versions of the ICC, ICC1 and ICC2,
using the following formulas:
ICC1~
sID
sTOT{sRun
~
sID
sIDzsID,Day
ð2Þ
ICC2~
sID
sTOT
~
sID
sIDzsID,DayzsRun
ð3Þ
ICC1 was calculated to estimate within-individual DNA
methylation stability, excluding pyrosequencing measurement
error (sRun). ICC2 includes all three sources of variability the
denominator. We fitted unadjusted models, as well as models
adjusted for PM10 exposure levels, age, current smoking, and
percent blood granulocytes. Percent blood granulocytes are the
most represented cell type among nucleated blood cells and were
therefore included in the adjusted models as an independent
variable to account for potential differences in DNA methylation
due to between-day changes in the proportions of leukocyte
subtypes. As a sensitivity analysis, we also added to the adjusted
models percent lymphocytes and percent monocytes. ICCs from
this sensitivity analysis (Table S2) did not show any major
differences from those calculated from the models adjusted only
for PM10, age, current smoking, and percent blood granulocytes.
To evaluate the potential determinants of the differences in
DNA methylation stability between the markers, we fitted simple
linear regression models in which the dependent variable was ICC
and the independent variable was one of the characteristics of the
methylation markers (i.e., G+C density, CpG(o/e), distance from
repeat elements at 39, distance from repeat elements at 59; mean
methylation value, or range of methylation). Covariate-adjusted
ICC1, as calculated above, were used in this set of analyses. In
addition to the linear models, we also tested non-linear relation-
ships between ICC and each of the marker characteristics via
regression models including a quadratic term. As sensitivity
analysis, we fit the same regression models after logit transforma-
tion of ICC, because ICC is a proportion ranged between 0 and 1
and non-normal distributed. Results from this set of sensitivity
analysis (shown in Table S3 and Figure S1) did not show major
departures from the results of the primary analysis. All statistical
analyses were performed in SAS (version 9.2; SAS Institute Inc.,
Cary, NC, USA).
Table 1. Sequence characteristics of the DNA methylation markers analyzed.
Gene G+C CpGo/e
Repeat elements:
distance at 3’
Repeat elements:
distance at 5’
# CpG positions
analyzed
APC 0.70 0.72 1847 371 4
CDH13 0.39 0.27 0.00 0.00 2
eNOS 0.66 0.29 592 1411 3
ET-1 0.60 0.86 2570 2264 4
hTERT 0.70 0.54 873 3466 3
IFNc 0.39 0.39 874 934 2
IL-6 0.59 0.59 460 1503 2
iNOS 0.56 0.19 1004 520 2
p16 0.72 0.74 699 1093 7
p53 0.57 0.56 1484 408 4
RASSF1A 0.64 0.69 1440 3208 4
TNFa 0.57 0.50 568 1327 4
Alu –* –* –* –* 3
LINE-1 –* –* –* –* 3
*Alu and LINE-1 were not considered, as repeat elements have multiple locations across the human genome with different context sequence characteristics.
doi:10.1371/journal.pone.0039220.t001
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Results
Levels and Characteristics of the DNA Methylation
Markers
We measured DNA methylation in 12 gene promoter regions
(APC, p16, p53, RASSF1A, CDH13, eNOS, ET-1, IFNc, IL-6,
TNFa, iNOS, and hTERT) and 2 of non-long terminal repeat
elements, i.e., LINE-1 and Alu (Table 1). The markers showed
extensive differences in the proportion of guanosine and
cytosine content (G+C), which varied between 0.39 (IFNc) and
0.72 (p16). The ratio of observed over expected CpG frequency
[CpG(o/e)] varied between 0.19 (iNOS) and 0.86 (ET-1). The
markers also had large differences in the distances from the
nearest repeat element in 59 (ranging between 0 bp [CDH13]
and 3.5 kB [hTERT]) and 39 (ranging between 0 bp [CDH13]
and 2.6 kB [ET-1]). In each marker, the assays we designed
allowed for measuring a variable number of CpG sites, ranging
from 2 to 7. The number of CpGs was dependent on the CpG
density in the vicinity of the target area, as we were able to
analyze a higher number of CpGs in sequences with higher
CpG density. In the statistical analysis, we used the average of
the CpG sites in each marker. We also conducted sensitivity
analyses using the methylation values at each of the CpG sites
within each marker, as shown below.
Mean DNA Methylation Difference between Day 1 and 4
APC, p16, and CDH13 showed small mean differences in DNA
methylation levels between Day 1 and 4 (Table 2). APC
methylation increased from 4.7% (SE= 0.13) to 4.9%
(SE= 0.13%) (difference = 0.2, 95% CI= 0.04; 0.44). p16 methyl-
ation increased from 2.2% (SE= 0.09) to 2.4% (SE= 0.09)
(difference = 0.2, 95% CI=0.04; 0.3). CDH13 methylation
decreased from 78.0% (SE= 0.33) to 77.4% (SE=0.35) (differ-
ence =20.6, 95% CI=21.1; 20.06). iNOS methylation de-
creased from 68.2% (SE= 0.46) to 67.6% (SE= 0.48) (differ-
ence =20.6, 95% CI=21.2; 20.02). All the other markers did
not show clear differences in DNA methylation between the two
time points. The analyses on individual CpGs were overall similar
to the analysis based on the mean of CpGs (Table S4).
Stability of DNA Methylation Markers
We used ICCs to describe the stability of the DNA methylation
markers between Day 1 and 4. ICCs capture both the mean and
within-individual differences of the individual data points, thus
providing an overall measure of biomarker stability. We decom-
posed the total variance in three components (Table 3), i.e., sID,
representing the between-individual variance in DNA methyla-
tion; sID, Day, representing the within-individual variance due to
changes in DNA methylation between Day 1 and 4; and sRun,
representing the variance between duplicate pyrosequencing runs
on the same sample (i.e., pyrosequencing error).
In unadjusted models (Table 3), the between-individual
variability (sID) varied between 0.15 (APC and p16) and 23.18
(IFNc). The within-individual variability between Day 1 and 4
(sID, Day) varied between 0.20 (Alu) and 11.18 (IFNc). Some of the
markers (i.e., RASFF1A and ET-1) had higher between- that
within-individual variability. Other markers (i.e., IL-6 and iNOS)
had higher within- than between-individual variability.
In unadjusted models that estimated ICCs subtracted of the
pyrosequencing measurement error (ICC1, see Table 3), IL-6
was the marker that showed the most stable methylation levels
between Day 1 and 4 [ICC1= 0.89]. APC was the marker that
showed the highest variation between the two time points
[ICC1=0.10]. Representative scatter plots for these two genes
are shown in Figure 1a (IL-6) and 1b (APC), respectively. ICCs
estimated without subtracting the pyrosequencing error (ICC2)
were only moderately lower than ICC1 (Table 3). In order to
adjust for the potential effects of PM10 exposure, as well as
potential confounding by age, current smoking and changes in
percent granulocytes in the blood counts, we also used models
fitting those covariates as independent variables to calculate
adjusted sID, sID, Day, and ICCs. Results from adjusted models
were remarkably similar to those from unadjusted models
(Table 3). We also performed additional set of analyses based
on individual CpGs with both unadjusted (Table S5a) and
adjusted models (Table S5b). The analyses on individual CpGs
generally showed similar stability across the CpG sites within in
the same gene (Table S4). However, in hTERT the CpG at
position 3 appeared moderately more stable (adjusted
ICC1= 0.57) than the CpGs at position 1 (adjusted
ICC1= 0.15) or 2 (adjusted ICC1= 0.30). Also, in p16 the
CpG at position 7 showed higher stability (adjusted
ICC1= 0.51) than the CpGs at positions 1–6 (adjusted ICC1
between 0.00 and 0.24).
In order to understand the sole effect of PM10 level in changing
DNA methylation during Day 1and Day 4, we examined the
association between exposed PM levels with DNA methylation in
each gene (Table S6 and S7). We also examined whether PM
levels were associated with increased or decreased percent
granulocytes, monocytes, or lymphocytes during these time points
(Table S8). Although DNA methylation of some of the genes was
associated with PM10, the variance of DNA methylation was not
influenced by the level of PM10, as shown by the adjusted models
in Table 3; nor the level of PM10 was associated with the percent
of granulocytes, monocytes, or lymphocytes.
Marker and Genomic Characteristics Associated with
DNA Methylation Stability
Figure 2 shows the correlations of ICCs with the marker and
genomic characteristics that we considered. In these analyses, we
used ICC1 values from adjusted models. To evaluate the
Table 2. Blood DNA methylation levels (%mC) in Day 1 and
Day 4 samples.
Gene Day 1 Day 4 Difference (95% CI)
Mean (SE) Mean (SE)
APC 4.7 (0.13) 4.9 (0.13) 0.2 (0.04; 0.4)
CDH13 78.0 (0.33) 77.4 (0.35) 20.6 (21.1; 20.06)
eNOS 91.9 (0.30) 92.0 (0.25) 0.1 (20.3; 0.6)
ET-1 6.2 (0.42) 6.3 (0.40) 0.1 (20.4; 0.6)
hTERT 92.6 (0.18) 92.6 (0.15) 0.0 (20.3; 0.4)
IFNc 73.8 (0.78) 73.0 (0.73) 20.8 (22.0; 0.4)
IL-6 42.6 (0.65) 42.6 (0.62) 20.0 (20.6; 0.6)
iNOS 68.2 (0.46) 67.6 (0.48) 20.6 (21.2; 20.02)
p16 2.2 (0.09) 2.4 (0.09) 0.2 (0.04; 0.3)
p53 6.2 (0.17) 6.3 (0.17) 0.1 (20.2; 0.3)
RASSF1A 7.5 (0.46) 7.1 (0.46) 20.4 (21.0; 0.2)
TNFa 12.8 (0.33) 12.5 (0.33) 20.3 (20.8; 0.2)
Alu 25.8 (0.10) 25.8 (0.08) 20.0 (20.2; 0.2)
LINE-1 78.8 (0.13) 78.8 (0.15) 20.0 (20.4; 0.2)
doi:10.1371/journal.pone.0039220.t002
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correlation of DNA methylation stability with CpG density, we
examined the GC content (G+C), as well as the ratio of observed-
to-expected [CpG(o/e)] within 6200bp from the first CpG site
analyzed. Both these measures showed negative correlation with
ICC (20.13 estimated change in ICC1 [95% CI 20.27; 0.01] per
a 0.1 increase in G+C, Figure 2a; and 20.08 estimated change in
ICC1 [95% CI 20.15; 20.02 per a 0.1 increase in CpG(o/e),
Figure 2b). These findings suggest that CpG-rich regions had
lower stability. The distance of repeat elements in 39 showed a
moderate negative correlation with the ICC values (20.20
estimated change in ICC1 [95% CI 20.40; 0.006] per each
1,000 nucleotides, Figure 2c). The distance of repeat elements in
59 did not show correlation with ICC (20.04 estimated change in
ICC1 [95% CI 20.2; 0.1] per each 1,000 nucleotides, Figure 2d).
The mean methylation of the markers on Day 1 did not show a
linear correlation with ICCs (Figure 2e). However, visual
inspection showed that the highest variations between Day 1
and 4 were found in markers with either high or low mean DNA
Table 3. Variance components and ICCs estimating the concordance between Day 1 and Day 4 DNA methylation measures.
Unadjusted Models
Models adjusted by PM10 exposure levels, age, current
smoking, and percent blood granulocytes
Marker sID sID, Day sRun ICC1 ICC2 sID sID, Day sRun ICC1 ICC2
APC 0.15 1.28 0.36 0.10 0.08 0.14 1.29 0.36 0.10 0.08
CDH13 4.98 2.36 0.25 0.68 0.66 4.72 2.26 0.25 0.68 0.65
eNOS 2.77 1.34 0.60 0.67 0.59 2.69 1.35 0.60 0.67 0.58
ET-1 4.92 7.30 0.13 0.40 0.40 5.37 7.33 0.13 0.42 0.42
hTERT 0.47 1.11 0.54 0.30 0.22 0.54 1.09 0.54 0.33 0.25
IFNc 23.18 11.18 0.23 0.67 0.67 18.27 9.94 0.23 0.65 0.64
IL-6 22.07 2.68 0.30 0.89 0.88 22.74 2.65 0.30 0.90 0.89
iNOS 11.28 2.52 0.30 0.82 0.80 11.53 2.54 0.30 0.82 0.80
p16 0.15 0.49 0.07 0.23 0.21 0.16 0.49 0.07 0.25 0.23
p53 0.53 1.65 0.23 0.24 0.22 0.58 1.64 0.23 0.26 0.24
RASSF1A 7.41 11.13 0.15 0.40 0.40 8.15 11.00 0.15 0.43 0.42
TNFa 4.40 1.69 0.17 0.72 0.70 3.67 1.70 0.17 0.68 0.66
Alu 0.12 0.20 0.27 0.39 0.21 0.11 0.20 0.27 0.37 0.20
LINE-1 0.59 0.98 0.33 0.38 0.31 0.59 0.96 0.33 0.38 0.31
Annotation: sID represents the between-subject variance in DNA methylation; sID, Day represents the variance due to within-subject changes in DNA methylation
between Day 1 and Day 4; sRun represents the variance between duplicate pyrosequencing runs on the same sample (i.e., analytical measurement error from
pyrosequencing). Two types of Intraclass Correlation Coefficients (ICCs) were computed using the quantities above: ICC1, subtracted of the measurement error (sRun),
was calculated as follows ICC1 = (sID/(sID+sID, Day)); and ICC2, which included the measurement error (sRun) at the denominator, was calculated as follows ICC2 = (sID/
(sID+sID, Day+sRun)).
doi:10.1371/journal.pone.0039220.t003
Figure 1. Representative scatter plots (Day 1 vs. Day 4 blood DNA methylation measures) of the biomarkers with highest (IL-6,
panel A) and lowest (APC, panel B) intra-class correlation coefficients.
doi:10.1371/journal.pone.0039220.g001
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methylation. By fitting a quadratic term regression, we found an
inverted U-shaped relation between mean DNA methylation and
ICCs (0.2 [95% CI 0.1; 0.4] for the linear term;22*1023, 95% CI
24*1023; 21*1023 for the quadratic term; both estimating the
change in ICC1 per 10% methylcytosine units of DNA methyl-
ation). The observed range of methylation on Day 1 was positively
correlated with ICC (0.2 estimated change in ICC1 [95% CI 0.1;
0.3] per 10% methyl-cytosine units of DNA methylation,
Figure 2f).
Discussion
In the present analysis of a set of DNA methylation markers, we
identified large marker-dependent differences in the short-term
variability of blood DNA methylation levels. We demonstrated
that at least some of these differences can be predicted using
characteristics of the nearby sequence – such as those describing
CpG density – as well as based on the mean and range of
methylation of the markers on Day 1. These results, albeit limited
to a small-sized population with a specific condition of exposure to
PM, provide a first set of information to identify methylation
markers with high short-term variability.
Based on early findings in cancer tissues that showed frequent
alterations in DNA cytosine methylation within promoter CpG
islands, CpG-rich regions have been a primary focus of functional
epigenetic studies [28,29]. However, recent data by Irizarry et al.,
suggesting that a majority of functional methylation sites reside in
regions less dense in CpGs termed CpG-island shores, have
directed DNA methylation studies toward sequences with lower
methylation density [10]. Because CpG-island shores have been
shown to constitute a large proportion of tissue-specific and
cancer-related methylation patterns [10], these sequences with
lower methylation density are now widely considered hot spots for
DNA methylation changes. In the present study based on DNA
methylation measures on blood leukocyte DNA, we found a
negative association between CpG nucleotide density and ICCs.
This finding indicates that DNA methylation in CpG-rich areas is
highly variable, whereas CpG-poor regions have more stable
methylation – at least over the short time period (i.e., three days)
evaluated. Key differences of our study compared with previous
data on CpG-island shores [10,30] are in the type of DNA source
and the study design that we used. Our analysis was specifically
conducted to draw inference for human studies using unfraction-
ated blood leukocytes as the DNA source for methylation analyses.
As we collected blood leukocyte DNA twice from each of the study
participants, we could directly differentiate the amount of inter-
individual and within-individual variability in the DNA methyl-
ation markers. However, evidence from previous functional studies
also supports our findings. DNA methyltransferases (DNMTs), the
best-characterized enzymes responsible for DNA methylation
changes in somatic human tissues, have been shown to bind to
specific genomic regions [31]. Recruiting of de-novo DNMTs is
preferential to CpG-rich sequences, such as CpG islands [32], and
could account for the higher short-term variation of DNA
methylation that we observed in CpG-rich sequences.
One interesting observation in the present study is the finding of
a marginal negative association between ICCs and the 39 distance
of repeat elements from the methylation sites analyzed. Repeat
elements may spread DNA methylation to adjacent genes [17].
Paradoxically, repeat elements have also been shown to serve as
insulators, protecting against de-novo DNA methylation [33]. In our
Figure 2. Correlations of intraclass correlation coefficients (ICCs) with DNA methylation levels and genomic characteristics of the
sequences analyzed. The panels show correlations of ICCs for each of the methylation biomarkers with content of guanosine and cytosine (G+C,
panel A); ratio of observed/expected CpG dinucleotides (CpG o/e; panel B); distance of repeat elements from 39 (panel C); distance of repeat elements
from 59 (panel D); DNA methylation mean on Day 1 (panel E); range of DNA methylation on Day 1 (panel F). The scatter plots use ICC values
subtracted of pyrosequencing measurement errors (ICC1) and estimated from models adjusted by PM10 exposure levels, age, current smoking, and
percent blood granulocytes. Each data point corresponds to the ICC1 value for one biomarker, as indicated by the corresponding label.
doi:10.1371/journal.pone.0039220.g002
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data, methylation markers closer to repeat elements were more
stable in time, suggesting that repeat elements may protect DNA
methylation of neighboring genes from short-term variation.
Previous investigations suggest that this finding may result from
interplays involving CCCTC-binding factor (CTCF), specificity
Protein 1 (SP1) and DNMTs. Repeat elements tend to be
associated with heterochromatin states and inactive histone
modifications, and are regarded as insulators that act like a
barrier against the influences of neighboring cis-acting elements
[34,35]. This molecular property of repeat elements might
underlie the high-stability of DNA methylation markers located
within a short distance of a repeat element.
In our analysis, we found that the markers with mean
methylation values close to 50% on Day 1 had the highest
stability whereas those close to 0% or 100% showed less
correlation between the two time points. We also found that the
range of DNA methylation observed on Day 1 was positively
correlated with the ICC values. As the markers with methylation
values close to 50% were also the ones with the largest ranges
(compare Figure 2e and 2f), this second finding is to be considered
closely related with the inverse U-shaped correlation observed
between mean DNA methylation and ICC. We suggest potential
ways through which DNA methylation showed levels around 50%.
The most obvious way is that methylation is derived from a variety
of cell types in blood leukocytes, and the mix of different
methylation patterns in each cell might determine the average
leucocyte methylation values. Whereas the mix of cell types may
determine differences in DNA methylation, our results of DNA
methylation stability were adjusted for the number and also the
proportion of different blood cell types. Another possibility is that
the two alleles present in each cell could be differentially
methylated, i.e. one of them methylated and the other unmethy-
lated. However, although this is the usual pattern found in
imprinted genes, allele-specific methylation is highly infrequent in
non-imprinted genes. None of the markers analyzed is known to
be imprinted. However, as we did not perform allele-specific
methylation analysis, we cannot exclude differential allelic
methylation based on our data. It is worth noting that, whereas
we computed ICCs net of pyrosequencing measurement error, we
did not run duplicates for bisulfite treatment and PCR-amplifica-
tion, which are other potential unmeasured sources of measure-
ment error. The association between larger methylation ranges
and ICCs may in part result from the influence of residual
measurement error, which is comparatively larger for the
biomarkers with smaller ranges.
We studied a group of individuals with well-characterized
environmental exposure to metal-rich air particles. In previous
analyses, we have shown in this group exposure-dependent
alterations of epigenetic and molecular markers related with pro-
inflammatory and oxidative properties of the exposure, including
DNA methylation [26,36], histone modifications [36], miRNAs
[37], telomere length [38], and mitochondrial DNA abundance
[27]. However, in the present study we found similar ICCs in
models with or without adjustment for PM10 levels. This finding
indicates that our estimates of the stability of DNA methylation
between Day 1 and 4 are independent from the levels of exposure
in the steel factory. The levels of individual PM10 exposure in this
study group ranged from high to low, and individuals with lower
exposures had PM10 levels similar to those found outdoors in
metropolitan areas in North America and Europe [26]. Therefore,
our results may extend to populations of individuals living in more
common environmental conditions.
We recognize several limitations to our investigation. Our
results are based on a limited selection of methylation markers,
which were available for the present analyses from previous and
ongoing studies on the effects of metal-rich particles on DNA
methylation. Our selection included markers related to inflamma-
tion, oxidative stress and cell-cycle control. Our results do not
necessarily apply to other markers. Nonetheless, the markers
analyzed included a variety of different genomic characteristics, as
well as a wide range of methylation levels, that allowed for
effectively testing the correlation of ICC with differences in CpG
density, distances from repeat elements, and DNA methylation
values on Day 1. Our marker selection is particularly limited if
compared with the high numbers of methylation sites that can be
analyzed using methylation arrays or other genome-scale ap-
proaches. However, bisulfite-PCR-pyrosequencing is the gold
standard for DNA methylation analyses in short (up to 80–100 bp)
sequences and provides measures that are considerably more
accurate and quantitative than microarray measures [39,40]. The
higher precision of pyrosequencing-based analyses is a critical
strength in the context of the statistical analyses presented in this
report. We recognize the small sample size as an additional
constraint that limited the precision of our statistical estimates.
Our statistical strategy, however, took advantage of some of the
strengths of the study, including the measurement of all
methylation markers in duplicates and the availability of
differential blood counts. We computed ICCs net of pyrosequenc-
ing error, we adjusted all results for percent granulocytes, and we
conducted sensitivity analyses that demonstrated that the results
were not dependent on changes in the proportion of other major
leukocyte cell types, i.e. granulocytes, monocytes and lymphocytes
(Table S2). However, some of the changes in DNA methylation
between Day 1 and 4 might have been determined by proliferation
of cell subpopulations within each of the major cell types (e.g.,
lymphocytic subpopulations). Whether short-term DNA methyla-
tion modifications in blood leukocytes are determined by actual
modifications of DNA methylation or rather by clonal expansion
of a subpopulation with distinctive methylation profiles remains to
be determined. Finally, we only examined two time points within
the same week. It is worth noting that our findings may not apply
to slower progressive changes in DNA methylation, such as those
associated with aging. Studies with a larger number of time points
over a longer time period may provide more detailed and accurate
information on cumulative long-term changes in DNA methyla-
tion.
In conclusion, we showed that DNA methylation markers in
blood DNA have different degrees of short-term variability. The
amount of variability in the methylation markers evaluated could
be predicted based on easy-to-obtain sequence information, such
as CpG density and distance from repeat element, as well as on the
average and range of methylation at the first measurement. Our
results provide information on short-term variability of methyla-
tion measures on blood leukocyte DNA, which are extensively
used in human studies. Whether these results can be extended to
other cell types remains to be determined in further investigations.
Supporting Information
Figure S1 Correlations of logit transformed ICCs with
genomic characteristics of the sequences analyzed. The
panels show correlations of logit transformed ICCs for each of the
methylation biomarkers with content of guanosine and cytosine
(G+C, panel A); ratio of observed/expected CpG dinucleotides
(CpG o/e; panel B); distance of repeat elements from 39 (panel C);
distance of repeat elements from 59 (panel D); DNA methylation
mean on Day 1 (panel E); range of DNA methylation on Day 1
(panel F). The scatter plots use ICC values subtracted of
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models adjusted by PM10 exposure levels, age, current smoking,
and percent blood granulocytes. Each data point corresponds to
the ICC1 value for one biomarker, as indicated by the
corresponding label.
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Correlation Coefficients (ICCs) were computed using the quan-
tities above: ICC1, subtracted of the measurement error (sRun),
was calculated as follows ICC1= (sID/(sID+sID, Day)); and ICC2,
which included the measurement error (sRun) at the denominator,
was calculated as follows ICC2= (sID/(sID+sID, Day+sRun)).
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(DOC)
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variance due to within-subject changes in DNA methylation
between Day 1 and Day 4; sRun represents the variance between
duplicate pyrosequencing runs on the same sample (i.e., analytical
measurement error from pyrosequencing). Two types of Intraclass
Correlation Coefficients (ICCs) were computed using the quan-
tities above: ICC1, subtracted of the measurement error (sRun),
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sample (i.e., analytical measurement error from pyrosequencing).
Two types of Intraclass Correlation Coefficients (ICCs) were
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